共 25 条
[1]
New developments in the treatment of psoriasis. Lebwohl M. Archives of Dermatology . 2002
[2]
Novel therapies for psoriasis. Cather J,Menter A. American Journal of Clinical Dermatology . 2002
[3]
Transplantation[P]. 英国专利:GB9904281D0,1999-04-21
[4]
Transplantation[P]. 英国专利:GB9904281D0,1999-04-21
[5]
Anti-CD4 monoclonal antibody treatment of moderate to severe psoriasis vulgaris: results of a pilot, multicenter, multiple-dose, placebo-controlled study. Gottlieb AB,Lebwohl M,Shirin S,et al. Journal of the American Academy of Dermatology . 2000
[6]
Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial. Chaudhari U,Romano P,Mulcahy LD,et al. The Lancet . 2001
[7]
The effectiveness of tumor necrosis factor alpha antibody(infliximab)in treating recalcitrant psoriasis:a report of2cases. O’Quinn RP,Miller JL. Archives of Dermatology . 2002
[8]
Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. Keane J,Gershon S,Wise RP,et al. The New England Journal of Medicine . 2001
[9]
Successful in vivo blockade of CD25 (high-affinity interleukin 2 receptor) on T cells by administration of humanized anti-Tac antibody to patients with psoriasis. Krueger JG,Walters IB,Miyazawa M,et al. Journal of the American Academy of Dermatology . 2000
[10]
CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris. Abrams JR,Lebwohl MG,Guzzo CA,et al. The Journal of Clinical Investigation . 1999